Search

everythinglearnresearchcommunity

for

Search:↓

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Finasteride may increase suicide risk; more research needed.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

Early balding at 40 increases prostate cancer risk.

Green tea may help with health issues like cancer, heart disease, and weight loss due to its high catechin content.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

A new compound was effective for imaging prostate cancer in rats.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

A new method accurately measures nine specific hormones in human blood.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Male pattern baldness may predict prostate cancer risk.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Suppressing certain hormones might help prevent prostate cancer.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.